Zymosan attenuates melanoma growth progression, increases splenocyte proliferation and induces TLR-2/4 and TNF-α expression in mice

BACKGROUND: Melanoma is one of the most common types of skin malignancies. Since current therapies are suboptimal, considerable interest has focused on novel natural-based treatments. Toll-like receptors (TLRs) play an important role in evoking innate immunity against cancer cells. Zymosan, a known...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Inflamm (Lond)
Main Authors: Taghavi, Mehdi, Mortaz, Esmaeil, Khosravi, Alireza, Vahedi, Ghasem, Folkerts, Gert, Varahram, Mohammad, Kazempour-Dizaji, Mehdi, Garssen, Johan, Adcock, Ian M.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5863857/
https://ncbi.nlm.nih.gov/pubmed/29588627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12950-018-0182-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados